Stop Fearing Incidental Findings
The article argues that patients should not fear incidental findings—unexpected abnormalities discovered during medical imaging—as they often lead to early detection of treatable conditions. It emphasizes that while some incidental findings may be benign, they provide valuable health information and can improve outcomes when properly managed by healthcare professionals.
Background
- Incidental findings are unexpected discoveries made during medical imaging (e.g., a kidney tumor spotted on a lung scan). They are extremely common in whole-body MRI as done by companies like Prenuvo and Ezra.
- The article argues against the medical establishment's long-standing advice to ignore or limit acting on incidentalomas, reflecting a shift now seen in radiology guidelines.
- "Overdiagnosis" vs. "early detection" is a key tension: some incidental findings lead to unnecessary, harmful treatment; others catch lethal diseases early. The debate is central to screening medicine.
- The backdrop is the rise of direct-to-consumer preventive imaging (often criticized by traditional doctors) and the pending FDA approval of an AI for incidental findings (Nines, a teleradiology AI firm).